Angle claims FDA okay for Parsortix liquid biopsy system May 25, 2022 May 25, 2022 Share X Angle claims FDA okay for Parsortix liquid biopsy system https://pharmaphorum.com/news/angle-claims-fda-okay-for-parsortix-liquid-biopsy-system/
Third FDA rejection for Verrica’s molluscum contagiosum drug May 25, 2022 May 25, 2022 Share X Third FDA rejection for Verrica’s molluscum contagiosum drug https://pharmaphorum.com/news/third-fda-rejection-for-verricas-molluscum-contagiosum-drug/
Pfizer’s Arena buyout looks canny, as etrasimod aces phase 3 trials May 25, 2022 May 25, 2022 Share X Pfizer’s Arena buyout looks canny, as etrasimod aces phase 3 trials https://pharmaphorum.com/news/pfizers-arena-buyout-looks-canny-as-etrasimod-aces-phase-3-trials/
NICE finds solution to making Keytruda available for TNBC May 25, 2022 May 25, 2022 Share X NICE finds solution to making Keytruda available for TNBC https://pharmaphorum.com/news/nice-finds-solution-to-making-keytruda-available-for-tnbc/
Angle claims FDA okay for Parsortix liquid biopsy system May 25, 2022 May 25, 2022 Share X Angle claims FDA okay for Parsortix liquid biopsy system https://pharmaphorum.com/news/angle-claims-fda-okay-for-parsortix-liquid-biopsy-system/
Third FDA rejection for Verrica’s molluscum contagiosum drug May 25, 2022 May 25, 2022 Share X Third FDA rejection for Verrica’s molluscum contagiosum drug https://pharmaphorum.com/news/third-fda-rejection-for-verricas-molluscum-contagiosum-drug/
Pfizer’s Arena buyout looks canny, as etrasimod aces phase 3 trials May 25, 2022 May 25, 2022 Share X Pfizer’s Arena buyout looks canny, as etrasimod aces phase 3 trials https://pharmaphorum.com/news/pfizers-arena-buyout-looks-canny-as-etrasimod-aces-phase-3-trials/
NICE finds solution to making Keytruda available for TNBC May 25, 2022 May 25, 2022 Share X NICE finds solution to making Keytruda available for TNBC https://pharmaphorum.com/news/nice-finds-solution-to-making-keytruda-available-for-tnbc/
Angle claims FDA okay for Parsortix liquid biopsy system May 25, 2022 May 25, 2022 Share X Angle claims FDA okay for Parsortix liquid biopsy system https://pharmaphorum.com/news/angle-claims-fda-okay-for-parsortix-liquid-biopsy-system/
Third FDA rejection for Verrica’s molluscum contagiosum drug May 25, 2022 May 25, 2022 Share X Third FDA rejection for Verrica’s molluscum contagiosum drug https://pharmaphorum.com/news/third-fda-rejection-for-verricas-molluscum-contagiosum-drug/
Pfizer’s Arena buyout looks canny, as etrasimod aces phase 3 trials May 25, 2022 May 25, 2022 Share X Pfizer’s Arena buyout looks canny, as etrasimod aces phase 3 trials https://pharmaphorum.com/news/pfizers-arena-buyout-looks-canny-as-etrasimod-aces-phase-3-trials/
NICE finds solution to making Keytruda available for TNBC May 25, 2022 May 25, 2022 Share X NICE finds solution to making Keytruda available for TNBC https://pharmaphorum.com/news/nice-finds-solution-to-making-keytruda-available-for-tnbc/
